This study is in progress, not accepting new patients
A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
Summary
- Eligibility
- for people ages 2-21 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Y-mAbs Therapeutics
- ID
- NCT05077423
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 36 study participants
- Last Updated